These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 21086040)

  • 21. Integrin beta3 Leu33Pro polymorphism and breast cancer risk: a population-based case-control study in Germany.
    Wang-Gohrke S; Chang-Claude J
    Breast Cancer Res Treat; 2004 Dec; 88(3):231-7. PubMed ID: 15609125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
    Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J
    Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A role for XRCC4 in age at diagnosis and breast cancer risk.
    Allen-Brady K; Cannon-Albright LA; Neuhausen SL; Camp NJ
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1306-10. PubMed ID: 16835328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients.
    Fasching PA; Loehberg CR; Strissel PL; Lux MP; Bani MR; Schrauder M; Geiler S; Ringleff K; Oeser S; Weihbrecht S; Schulz-Wendtland R; Hartmann A; Beckmann MW; Strick R
    Breast Cancer Res Treat; 2008 Nov; 112(1):89-98. PubMed ID: 18049890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of DLG5 variants with gluten-sensitive enteropathy.
    Festen EA; Zhernakova A; Wijmenga C; Weersma RK
    Gut; 2008 Jul; 57(7):1027-8. PubMed ID: 18559397
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer.
    Choi JY; Lee KM; Park SK; Noh DY; Ahn SH; Chung HW; Han W; Kim JS; Shin SG; Jang IJ; Yoo KY; Hirvonen A; Kang D
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1090-5. PubMed ID: 15894657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer.
    Lesueur F; Pharoah PD; Laing S; Ahmed S; Jordan C; Smith PL; Luben R; Wareham NJ; Easton DF; Dunning AM; Ponder BA
    Hum Mol Genet; 2005 Aug; 14(16):2349-56. PubMed ID: 16000320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer.
    Kotsopoulos J; Zhang WW; Zhang S; McCready D; Trudeau M; Zhang P; Sun P; Narod SA
    Breast Cancer Res Treat; 2008 Dec; 112(3):585-93. PubMed ID: 18204969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scribble, Lgl1, and myosin II form a complex in vivo to promote directed cell migration.
    Abedrabbo M; Ravid S
    Mol Biol Cell; 2020 Sep; 31(20):2234-2248. PubMed ID: 32697665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ZDHHC7-mediated S-palmitoylation of Scribble regulates cell polarity.
    Chen B; Zheng B; DeRan M; Jarugumilli GK; Fu J; Brooks YS; Wu X
    Nat Chem Biol; 2016 Sep; 12(9):686-93. PubMed ID: 27380321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant overexpression of the cell polarity module scribble in human cancer.
    Vaira V; Faversani A; Dohi T; Maggioni M; Nosotti M; Tosi D; Altieri DC; Bosari S
    Am J Pathol; 2011 Jun; 178(6):2478-83. PubMed ID: 21549346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LIN7A is a major determinant of cell-polarity defects in breast carcinomas.
    Gruel N; Fuhrmann L; Lodillinsky C; Benhamo V; Mariani O; Cédenot A; Arnould L; Macgrogan G; Sastre-Garau X; Chavrier P; Delattre O; Vincent-Salomon A
    Breast Cancer Res; 2016 Feb; 18(1):23. PubMed ID: 26887652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VEGF 936C>T polymorphism and breast cancer risk: evidence needed further clarification.
    Liu L; Hua FZ; Cao JQ; Zhu PQ
    Breast Cancer Res Treat; 2011 Jun; 127(2):569-71. PubMed ID: 21249444
    [No Abstract]   [Full Text] [Related]  

  • 34. [Relationship between polarity variation of epithelium and breast cancer].
    Xie J; Yang YL; Li YQ; Fu L
    Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):212-4. PubMed ID: 23769448
    [No Abstract]   [Full Text] [Related]  

  • 35. Distribution of breast cancer risk from SNPs and classical risk factors in women of routine screening age in the UK.
    Brentnall AR; Evans DG; Cuzick J
    Br J Cancer; 2014 Feb; 110(3):827-8. PubMed ID: 24448363
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetic screening could improve breast cancer prevention, study finds.
    Kmietowicz Z
    BMJ; 2015 Apr; 350():h1879. PubMed ID: 25858913
    [No Abstract]   [Full Text] [Related]  

  • 37. No association of polymorphisms in the cell polarity gene SCRIB with breast cancer risk in German population.
    Zhang C; Zhou P; Li JP
    Breast Cancer Res Treat; 2011 Feb; 126(1):257-9. PubMed ID: 21086040
    [No Abstract]   [Full Text] [Related]  

  • 38. No association of polymorphisms in the cell polarity gene SCRIB with breast cancer risk.
    Dünnebier T; Schlaefer K; Gilbert M; Baisch C; Justenhoven C; Brauch H; Harth V; Spickenheuer A; Rabstein S; Pesch B; Brüning T; Ko YD; Hamann U
    Breast Cancer Res Treat; 2011 May; 127(1):259-64. PubMed ID: 20936341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Scrib, a tumor suppressor gene involved in cell polarity].
    Osmani N; Etienne-Manneville S
    Med Sci (Paris); 2008 Jan; 24(1):61-4. PubMed ID: 18198112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased Usage of Specific Scrib Exons Defines a More Malignant Phenotype of Breast Cancer With Worsened Survival.
    Metodieva G; Adoki S; Lausen B; Metodiev MV
    EBioMedicine; 2016 Jun; 8():150-158. PubMed ID: 27428426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.